Drugs / activated DCs
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03410732 | Jul 2017 → Jul 2020 | gastric cancer | LanZhou University | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | activated DCs | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03410732 ↗ |
| Modality | Cell therapy | “activated autologous dendritic cells (DCs)” NCT03410732 ↗ |
| Route | Intravenous | “Then the activated DCs are iv infused in 21 days after a radical surgery.” NCT03410732 ↗ |